Dallas, TX, April 21, 2016 --(PR.com
)-- The Global Internal Neuromodulation devices market is driven by the rising incidence of failed back surgeries, Parkinson’s disease, urinary incontinence and other related indications. Also the market is experiencing a rising surge of technological advancements such as the new internal neuromodulation device from Enteromedics for the treatment of obesity related disorders. The market is in its lag phase very soon expected to enter the growth phase, due to major influx of market players in the recent years.
The Internal neuromodulation devices market is segmented into 5 product types Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator and Gastric Nerve Stimulator. The Spinal Cord Stimulator segment dominates the internal neuromodulator devices market globally followed by deep brain stimulator and vagus nerve stimulator. The market is further segmented based on indications of usage into Failed Back Surgery Syndrome, Conditional Regional pain syndrome, Eschemia, Parkinson’s disease, Alzheimers, Urinary Incontinence, Faecal Incontinenece, Epilepsy, Gastroparesis and others. The product segments are further divided into rechargeable and primary battery types also for spinal cord stimulators the market is divided into 2 lead types percutaneous and paddle lead.
The internal neuromodulation devices market is segmented into 4 geographies North America, Europe, Asia-Pacific and Rest of the World. North America is the largest market while Asia-Pacific is the fastest growing market due to the large incidence of Parkinson’s disease in the Asian countries like China. Europe is a developed market with increasing demand for these devices due to good reimbursement scenarios and medical tourisms in countries like Germany, Ireland, Netherlands and others.
The report also covers a complete competitive landscape including the company shares, recent developments, mergers and acquisitions, new product launches and company profiles with product and revenue matrix. Some of the major players operating in this market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Inc., Nexro Corporation, Cyberonics, Inc. among other companies.
For free sample of the report